ImmunityBio, Inc. (IBRX) Stock Price History
Historical prices from 2015 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
IBRX Stock Price Trajectory (2015–2026)
As of March 2, 2026, ImmunityBio, Inc. (IBRX) trades at $9.78, representing a +197.3% return over the past year. The stock has delivered a -21.7% return over five years, reflecting challenging market conditions.
The stock reached its all-time high of $45.42 on February 22, 2021. From this peak, IBRX has corrected -78.5%, currently trading 206% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers RVMD (+150.4% 1Y), INCY (+37.8% 1Y), and GMAB (+29.8% 1Y), IBRX has outperformed the peer group average. Compare IBRX vs RVMD →
Historical Price Data
Showing 30 of 2,664 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 9.41 | 9.80 | 8.83 | 9.78 | 9 | +2.41% |
| 2026-02-26 | 9.90 | 9.97 | 8.98 | 9.55 | 9 | +0.10% |
| 2026-02-25 | 12.17 | 12.43 | 9.38 | 9.54 | 9 | -17.40% |
| 2026-02-24 | 10.15 | 12.27 | 9.95 | 11.55 | 11 | +17.50% |
| 2026-02-23 | 9.93 | 11.00 | 9.56 | 9.83 | 9 | +12.99% |
| 2026-02-20 | 8.63 | 9.25 | 8.32 | 8.70 | 8 | +1.05% |
| 2026-02-19 | 8.07 | 8.94 | 7.60 | 8.61 | 55.05M | +0.82% |
| 2026-02-18 | 6.06 | 8.68 | 6.06 | 8.54 | 78.55M | +41.69% |
| 2026-02-17 | 6.26 | 6.28 | 5.93 | 6.03 | 4.06M | +1.39% |
| 2026-02-13 | 6.62 | 7.30 | 5.94 | 5.95 | 39.28M | -10.20% |
| 2026-02-12 | 6.53 | 6.87 | 6.40 | 6.62 | 13.39M | +1.22% |
| 2026-02-11 | 6.72 | 6.77 | 6.28 | 6.54 | 17.18M | -0.30% |
| 2026-02-10 | 6.95 | 7.14 | 6.55 | 6.56 | 21.94M | -5.34% |
| 2026-02-09 | 6.05 | 7.03 | 5.82 | 6.93 | 23.92M | +14.55% |
| 2026-02-06 | 5.70 | 6.08 | 5.61 | 6.05 | 18.04M | +7.27% |
| 2026-02-05 | 5.72 | 5.98 | 5.58 | 5.64 | 18.24M | -4.08% |
| 2026-02-04 | 6.29 | 6.29 | 5.69 | 5.88 | 21.38M | -7.11% |
| 2026-02-03 | 6.14 | 6.54 | 5.95 | 6.33 | 21.12M | +3.26% |
| 2026-02-02 | 6.29 | 6.75 | 5.93 | 6.13 | 24.29M | -1.92% |
| 2026-01-30 | 5.78 | 6.46 | 5.67 | 6.25 | 29.31M | +5.75% |
| 2026-01-29 | 6.15 | 6.35 | 5.73 | 5.91 | 24.40M | -3.90% |
| 2026-01-28 | 6.01 | 6.29 | 5.54 | 6.15 | 35.03M | +3.36% |
| 2026-01-27 | 5.96 | 6.13 | 5.59 | 5.95 | 38.51M | -4.19% |
| 2026-01-26 | 6.66 | 6.75 | 6.16 | 6.21 | 37.42M | -3.72% |
| 2026-01-24 | 7.40 | 7.88 | 6.43 | 6.45 | 74.58M | 0.00% |
| 2026-01-23 | 7.38 | 7.88 | 6.43 | 6.45 | 75.85M | -12.13% |
| 2026-01-22 | 7.45 | 8.28 | 6.90 | 7.34 | 80.85M | +6.07% |
| 2026-01-21 | 6.27 | 7.10 | 5.71 | 6.92 | 95.69M | +6.79% |
| 2026-01-20 | 6.54 | 7.98 | 6.08 | 6.48 | 210.43M | +17.39% |
| 2026-01-16 | 4.70 | 5.58 | 4.38 | 5.52 | 177.80M | +39.75% |
See IBRX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IBRX Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare IBRX vs AGIO
See how IBRX stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has IBRX stock performed recently?
IBRX returned +197.3% over the past year, beating its 5-year annualized CAGR of -21.7%. The stock trades above its 200-day moving average, confirming the uptrend.
What is IBRX's all-time high price?
ImmunityBio, Inc. reached $45.42 on 2021-02-22. The 52-week high is $12.43. Current 1-year return of +197.3% places the stock closer to historical peaks.
Where can I download IBRX historical price data?
This page provides IBRX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2015-2026, downloadable in CSV format.